If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Digital Technology » Digital Technology and Innovation
Download FREE Excerpt
18 Info Graphics
19 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Faced with a rapidly evolving healthcare environment, biopharmaceutical companies are relying on innovative digital marketing strategies to effectively reach out to customers throughout the product lifecycle. This research examines how pharmaceutical companies optimize their digital service delivery to support internal customers and nurture strong digital-brand partnerships. The study also explores the use of analytics for better digital marketing insights and current approaches to data governance within the pharma sector.
The study will help digital marketing leaders better understand the utilization of mobile tools to improve customer engagement and sales force effectiveness, the deployment of advanced analytics for better targeting and performance, and the current state of data governance in pharma.
This study delivers segment perspectives on large, mid-cap and small companies as well as global vs. U.S.-only companies.
Best Practices, LLC engaged 48 Digital Marketing leaders at 42 companies through a benchmarking survey instrument. Representatives from 8 companies participated in deep-dive interviews.
Pharmaceutical; Marketing; Diagnostic; Health Care; Consumer Products; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Medical Device; Science
Teva Pharmaceutical Industries Ltd; Triplefin; Chiesi; biokit; Abbott; Precision Therapeutics; Abbvie; Meridian Bioscience; Merck; Vivus; Bayer Healthcare; MD Outlook; Sanofi; Pfizer; Takeda Pharmaceuticals; Roche; Boehringer Ingelheim; GlaxoSmithKline ; Amgen; Novo Nordisk; Covidien; LEO Pharma; Biogen Idec; Olympus Corporation; Eisai; Mylan; UCB Pharma; Ferring Pharmaceuticals; Lundbeck; Catalent Pharma Solutions; Astellas; CSL Behring; Ranbaxy; Galderma; Boston Scientific; Edward Lifesciences; Purdue Pharma; Nektar Therapeutics; Merial; Genomic Health; Cochlear; Haemonetics Corporation
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.